A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics.
暂无分享,去创建一个
Nathaniel Hupert | Amanda Honeycutt | Michael L. Washington | N. Hupert | Olga A. Khavjou | M. Messonnier | A. Honeycutt | M. L. Washington | Katherine A. Hicks | Bo-Hyun Cho | Olga Khavjou | Mark L. Messonnier | Bo-Hyun Cho | K. Hicks
[1] G. Pugliese,et al. Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.
[2] M. Meltzer,et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. , 2000, JAMA.
[3] K. Nichol,et al. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. , 2003, Vaccine.
[4] S. Humiston,et al. A personnel time-motion study of intranasal influenza vaccination in healthy children. , 2005, Vaccine.
[5] M. Meltzer,et al. Estimating medical practice expenses from administering adult influenza vaccinations. , 2005, Vaccine.
[6] J. Mauskopf,et al. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. , 2007, Vaccine.
[7] M. L. Washington,et al. Evaluating the Capability and Cost of a Mass Influenza and Pneumococcal Vaccination Clinic via Computer Simulation , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] H. Hull,et al. Strategies for implementing school-located influenza vaccination of children: a systematic literature review. , 2010, The Journal of school health.
[9] P. Effler,et al. Statewide School-located Influenza Vaccination Program for Children 5–13 Years of Age, Hawaii, USA , 2010, Emerging infectious diseases.
[10] T. Lieu,et al. Non-Traditional Settings for Influenza Vaccination of Adults , 2012, PharmacoEconomics.